The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, BioNTech SE ADR’s stock clocked out at $92.08, down -2.56% from its previous closing price of $94.50. In other words, the price has decreased by -$2.56 from its previous closing price. On the day, 0.63 million shares were traded. BNTX stock price reached its highest trading level at $95.465 during the session, while it also had its lowest trading level at $91.5.
Ratios:
To gain a deeper understanding of BNTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.02 and its Current Ratio is at 10.18. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $145.
On January 10, 2025, Truist started tracking the stock assigning a Buy rating and target price of $172.
On December 11, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $170.Wells Fargo initiated its Overweight rating on December 11, 2024, with a $170 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 07 ’25 when Jeggle Helmut Wolfgang bought 150,000 shares for $94.74 per share.
Richardson Ryan bought 26,500 shares of BNTX for $3,021,000 on Feb 27 ’25. On Feb 20 ’25, another insider, Medine GmbH, who serves as the Officer of the company, bought 1,000,000 shares for $119.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BNTX now has a Market Capitalization of 22136588288 and an Enterprise Value of 8319754752. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.46 while its Price-to-Book (P/B) ratio in mrq is 1.08. Its current Enterprise Value per Revenue stands at 3.029 whereas that against EBITDA is -8.157.
Stock Price History:
The Beta on a monthly basis for BNTX is 1.29, which has changed by -0.009625733 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, BNTX has reached a high of $131.49, while it has fallen to a 52-week low of $76.53. The 50-Day Moving Average of the stock is -6.87%, while the 200-Day Moving Average is calculated to be -13.79%.
Shares Statistics:
It appears that BNTX traded 1.12M shares on average per day over the past three months and 919330 shares per day over the past ten days. A total of 240.39M shares are outstanding, with a floating share count of 236.70M. Insiders hold about 1.54% of the company’s shares, while institutions hold 20.92% stake in the company. Shares short for BNTX as of 1745971200 were 4634420 with a Short Ratio of 4.14, compared to 1743379200 on 3630255. Therefore, it implies a Short% of Shares Outstanding of 4634420 and a Short% of Float of 5.0200000000000005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
